Shenzhen Hepalink Pharma, MBV Int'l drop on Hong Kong debuts

Shenzhen Hepalink Pharmaceutical Co

08/07/2020 05:45

** Shares of Hong Kong stock market debutants Shenzhen
Hepalink Pharmaceutical Group Co Ltd  9989.HK  and MBV
International Ltd  1957.HK  fall at open   
    ** Shenzhen Hepalink drops as much as 4.9% from the offer
price to HK$17.50, while MBV slumps 51.9% from IPO price of
HK$0.80
    ** Shenzhen Hepalink's Shenzhen-listed stock falls 4.1%    
    ** Raised about HK$4 bln ($516 mln) after selling 220.09 mln
H shares at the bottom of the HK$18.40–$20.60/share range 
    ** To use proceeds to repay debt, expand sales network and
manufacturing capacity, and invest in innovative drugs
    ** Johor, Malaysia-based MBV, a supplier of imprintable
apparel and gift products, offered 157 mln shares and raised
HK$125.6 mln to enhance warehousing and to improve logistics (https://bit.ly/2Z9xeTC)
    ** The Hang Seng China enterprises index  .HSCE  gains 1.2%,
while the Hong Kong benchmark index  .HSI  rises 0.3%
    ($1 = 7.7501 Hong Kong dollars)

 (Reuters Messaging: donny.kwok.thomsonreuters.com@reuters.net)